Nikhil Ananth

Senior Associate
Cambridge
Nikhil Ananth
LinkedIn

Nikhil Ananth

Senior Associate
Cambridge

Nikhil is a Senior Associate at F-Prime and works across the healthcare sub-sectors including therapeutics, medical technology, life sciences tools, and healthcare IT & services. Prior to joining F-Prime in 2019, Nikhil was an Associate at Audax Group in Boston, where he focused on private equity investments in healthcare and software.

Nikhil is a graduate of the University of Pennsylvania’s Vagelos Program in Life Sciences & Management, where he received a B.A. in Biology and a B.S. in Economics from the Wharton School.

Portfolio

Uses genome-wide methylation analysis for earlier, precise cancer and morbidity detection.
Redefining PCR with single-molecule precision and category-defining sensitivity.
Developing curative medicines through precision in vivo cellular engineering.
Specializing in biosimilars and novel biologics for global healthcare markets.
Focused on affordable, high-quality medicines for patients worldwide.
Improving diagnostic testing and accelerate drug discovery in diverse underserved populations.
Leading the change in cell & gene therapies & personalized immunotherapy.
Developing novel protein-based therapeutics for companion animals.
Acquired by Dechra
Eliminating infusion-related patient harm.
Acquired by Fresenius Kabi
Engineering microbes to produce animal-free proteins and growth factors for biopharma, food, health, and personal care markets.
Developing next-generation medicines for obesity and metabolic diseases.
NASDAQ: MTSR
Offers clean-label wellness supplements for health-conscious consumers through plant-based nutrition.
Developing transformative therapies for devastating rare diseases.
NASDAQ: RLYB